Cigna Corporation (NYSE:CI) Scheduled to Post Earnings on Friday

Cigna Corporation (NYSE:CI) is scheduled to post its quarterly earnings results before the market opens on Friday, August 4th. Analysts expect Cigna Corporation to post earnings of $2.47 per share for the quarter. Cigna Corporation has set its FY17 guidance at $9.25-9.75 EPS.

Cigna Corporation (NYSE:CI) last posted its earnings results on Friday, May 5th. The health services provider reported $2.77 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.44 by $0.33. Cigna Corporation had a return on equity of 16.07% and a net margin of 6.53%. The firm had revenue of $10.39 billion for the quarter, compared to analysts’ expectations of $10.11 billion. During the same period in the previous year, the firm earned $2.46 earnings per share. The business’s revenue was up 5.1% compared to the same quarter last year. On average, analysts expect Cigna Corporation to post $9.79 EPS for the current fiscal year and $11.20 EPS for the next fiscal year.

Cigna Corporation (NYSE CI) opened at 172.96 on Wednesday. The stock’s 50 day moving average price is $170.76 and its 200 day moving average price is $157.68. The stock has a market capitalization of $44.28 billion, a PE ratio of 23.09 and a beta of 0.46. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $175.80.

Several research firms have recently issued reports on CI. UBS AG reaffirmed a “buy” rating and issued a $186.00 price objective (up from $181.00) on shares of Cigna Corporation in a research note on Monday, June 5th. Bank of America Corp raised their price objective on Cigna Corporation from $193.00 to $198.00 and gave the company a “buy” rating in a research note on Friday, June 23rd. Jefferies Group LLC reissued a “buy” rating and set a $183.00 price target on shares of Cigna Corporation in a research note on Thursday, June 8th. Zacks Investment Research lowered Cigna Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, April 5th. Finally, ValuEngine lowered Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 20th. Two research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company. Cigna Corporation has a consensus rating of “Buy” and an average target price of $176.61.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by [[site]] and is owned by of [[site]]. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at [[permalink]].

In other news, EVP Nicole S. Jones sold 20,312 shares of Cigna Corporation stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $160.04, for a total value of $3,250,732.48. Following the transaction, the executive vice president now directly owns 44,737 shares in the company, valued at approximately $7,159,709.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Mary T. Hoeltzel sold 500 shares of Cigna Corporation stock in a transaction on Tuesday, June 6th. The shares were sold at an average price of $166.70, for a total value of $83,350.00. Following the completion of the transaction, the vice president now owns 2,449 shares in the company, valued at $408,248.30. The disclosure for this sale can be found here. Insiders have sold a total of 219,558 shares of company stock worth $37,135,665 over the last 90 days. 1.30% of the stock is currently owned by company insiders.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.